Analyst Profile

Followed by 382 followers
.
Madhu Kumar

Madhu Kumar

Goldman Sachs
Wall Street Analyst
#413 out of 8,160 Wall Street Analysts
#790 out of 24,427 experts

Success Rate

49%
154 out of 315 transactions made a profit

Average Return

+15.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Madhu Kumar's trades since 2015 and holding each position for 1 Year would result in 48.89% of your transactions generating a profit, with an average return of 15.3% per rating.

Stock Rating Distribution

546Ratings
68.86% Buy
22.53% Hold
8.61% Sell
Distribution of Madhu Kumar's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Arcturus Therapeutics
(ARCT)
Rating:Buy
Date:Feb 10, 2020 - Feb 10, 2021
Return:+557.70%
The most profitable rating made by Madhu Kumar

Madhu Kumar's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Histogen
Sep 25, 2015
Hold
Reiterated
$5.00
(385.44% Upside)
1Ratings
0.00%
Novartis
Jan 23, 2017
Buy
Reiterated
1Ratings
100%
+28.10%
Catalyst Biosciences
Jun 12, 2017
Buy
Initiated
$10.00
(1718.18% Upside)
1Ratings
100%
+450.10%
Clovis Oncology
Aug 04, 2017
Hold
Reiterated
7Ratings
0%
-33.00%
Crispr Therapeutics AG
Aug 11, 2017
Buy
Reiterated
$25.00
(-54.13% Downside)
2Ratings
100%
+145.00%
ProQR
Aug 17, 2017
Hold
Reiterated
5Ratings
0.00%
~ACHN
Achillion Pharmaceuticals
Feb 23, 2018
Hold
Reiterated
12Ratings
75%
+37.25%
Akari Therapeutics
Mar 22, 2018
Hold
Reiterated
$2.50
(364.08% Upside)
7Ratings
100%
+64.10%
Fortress Biotech
Jul 03, 2018
Buy
Reiterated
$10.00
(1435.39% Upside)
2Ratings
0%
-49.75%
IMMU
Immunomedics
Aug 24, 2018
Buy
Reiterated
4Ratings
0%
-43.87%
List of latest recommendations made by Madhu Kumar. Click to expand and see Madhu Kumar's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >